Loading stock data…
$3.07-0.01 (-0.32%)
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA Technologies, Inc. in the Healthcare sector is trading at $3.07 with a market capitalization of $230M. The stock is currently near its 52-week low of $2.83, remaining 29.3% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $41.00M↑ | $6.24M↑ | $3.79M↑ | $2.62M↓ | $81.12M |
| Gross Profit | $23.44M↑ | $3.30M↑ | $804,474↓ | $1.62M↓ | $55.57M |
| Operating Income | $13.91M↑ | -$5.32M↑ | -$9.50M↑ | -$10.22M↓ | $45.68M |
| Net Income | $12.46M↑ | -$3.45M↑ | -$5.43M↑ | -$6.37M↓ | $35.48M |
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus...